Trademark: 97207825
Word
NEXT LEVEL IMMUNO-ONCOLOGY
Status
Pending
Status Code
630
Status Date
Monday, January 17, 2022
Serial Number
97207825
Mark Type
5000
Filing Date
Friday, January 7, 2022

Trademark Owner History

Classifications
5 Pharmaceutical preparations and articles, namely, medical gas being nitric oxide for medical purpose to be used at home or in a hospital; gases for medical purposes, namely, nitric oxide for medical purposes and ultra-high nitric oxide for the treatment of tumors and cancer; chemical preparations for medical purposes, namely, for tumors, cancer, chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium; chemical preparations for pharmaceutical purposes, namely, for tumors, cancer, chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium; Pharmaceutical preparation for tumors, cancer, chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium; Medical preparation for tumors, cancer, chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium
10 Medical apparatus and instruments, namely, device for the delivery of medical gas to be used at home or in a hospital; Diagnostic, examination, and monitoring equipment, namely, medical and medicine diagnostic systems, detection systems, monitoring systems for tumors, cancer, chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium, delivery systems of nitric oxide for the treatment of chronic obstructive pulmonary disease, cystic fibrosis, bronchiolitis, and non-tuberculosis mycobacterium, and delivery systems of ultra-high nitric oxide for the treatment of tumors and cancer; apparatus and instruments for use in connection with the administration of gases to patients for medical and therapeutic purposes, namely, medical and therapeutic gas delivery systems; apparatus and instruments for setting, measuring and regulating the mixture of medical and therapeutic gases delivered to patients
42 Scientific research for medical purposes in the area of tumors, cancer, and respiratory diseases; medical research services, namely, conducting clinical trials for others; scientific research, namely, research on the use of nitric oxide and ultra-high nitric oxide for medical purposes; Scientific research, namely, research on preparations and treatments for tumors, cancer, and respiratory diseases
Color is not claimed as a feature of the mark.
The mark consists of The mark consists of the words Next Level ImmuNO-oncology in which "Next" has a capital "N" and "Level" begins with a capital "L". "ImmuNO" and "oncology" are hyphenated in which "ImmuNO" has a capital "I", a capital "N" and a capital "O" and "oncology" appears in all lowercase letters.

Trademark Events
Jan 13, 2022
New Application Office Supplied Data Entered In Tram
Jan 11, 2022
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24